Roy Abhik, Smith Colin, Daskalakis Constantine, Voorhees Kristin, Moleski Stephanie, DiMarino Anthony J, Kastenberg David
Department of Medicine, Thomas Jefferson University; 132 South 10th Street, Suite 480, Philadelphia, PA 19107, the United States.
Division of Biostatistics, Thomas Jefferson University; 1015 Chestnut Street, Suite M-100 Mezzanine, Philadelphia, PA 19107, the United States.
J Gastroenterol Hepatol Res. 2015 Dec;4(12):1838-1843. doi: 10.17554/j.issn.2224-3992.2015.04.585. Epub 2015 Dec 21.
Screening first-degree relatives of celiac disease (CD) patients offers an opportunity to diagnose CD in a high-risk population.This study aims to determine how frequently CD patients receive a physician-issued recommendation for first-degree relative screening.
A 12-question survey assessing whether CD patients receive a physician recommendation to screen first-degree relatives for CD, and the impact of such a recommendation, was validated with outpatients in a university gastroenterology practice ("University"). The 12-question survey was then distributed online to members of a celiac organization - the National Foundation for Celiac Awareness ("NFCA"). Results were collected over 3 months. Univariate analysis was used to compare cohort means and assess the association between demographic and diagnostic factors and first-degree relative screening recommendations.
87 University patients participated in the validation phase. Test-retest reliability of 4 key survey questions was high (Kappa coefficient > 0.80). The main analyses were based on data from 677 NFCA and 82 University respondents. Respondents were predominantly female, with a mean age of 45 years. Significantly more University patients received a recommendation for screening (78% 44%, < 0.001). Ninety-eight percent receiving a screening recommendation (both groups) discussed this with family members, leading to CD screening (University 71%, NFCA 79%) and, ultimately, a CD diagnosis (University 18%, NFCA 27%).
Physicians of CD patients often do not recommend screening first-degree family members. The high clinical impact of this recommendation suggests that greater physician compliance with screening may increase the diagnosis of CD in high risk individuals.
对乳糜泻(CD)患者的一级亲属进行筛查,为在高危人群中诊断CD提供了机会。本研究旨在确定CD患者接受医生发出的一级亲属筛查建议的频率。
一项包含12个问题的调查问卷,评估CD患者是否收到医生关于对一级亲属进行CD筛查的建议以及该建议的影响,该问卷在一所大学胃肠病科诊所(“大学诊所”)对门诊患者进行了验证。然后,这份包含12个问题的调查问卷在网上分发给了一个乳糜泻组织——全国乳糜泻意识基金会(“NFCA”)的成员。结果收集了3个月。采用单因素分析比较队列均值,并评估人口统计学和诊断因素与一级亲属筛查建议之间的关联。
87名大学诊所患者参与了验证阶段。4个关键调查问题的重测信度很高(卡帕系数>0.80)。主要分析基于677名NFCA受访者和82名大学诊所受访者的数据。受访者以女性为主,平均年龄45岁。显著更多的大学诊所患者收到了筛查建议(78%对44%,P<0.001)。98%收到筛查建议的患者(两组)与家庭成员讨论了此事,从而进行了CD筛查(大学诊所71%,NFCA 79%),最终确诊为CD(大学诊所18%,NFCA 27%)。
CD患者的医生通常不建议对一级家庭成员进行筛查。该建议具有较高的临床影响,这表明医生更高的筛查依从性可能会增加高危个体中CD的诊断率。